Navigation Links
Delmarva Foundation Implements Medication Therapy Management Program in Maryland and DC
Date:9/26/2007

Local Quality Improvement Organization is part of national effort to

improve health of Medicare beneficiaries

HANOVER, Md., Sept. 26 /PRNewswire-USNewswire/ -- Quality Improvement Organizations (QIOs) across the country are working in partnership with Medicare Part D prescription drug plans (PDPs) and Medicare Advantage plans (MA-PDs) to improve the quality of prescription drug therapy for Medicare beneficiaries. Delmarva Foundation, Medicare's QIO for Maryland and the District of Columbia, implemented a program aimed at helping Medicare beneficiaries use prescription drugs more appropriately and effectively at their local pharmacies.

Through collaboration among Medi-CareFirst BlueCross BlueShield, University of Maryland School of Pharmacy, Howard University School of Pharmacy, and Delmarva Foundation, this program seeks to improve the safety and quality of prescription drug therapy via use of medication therapy management services (MTMS) in community-based pharmacies. MTMS focuses on improving patients' understanding of the medications they are taking and assessing patients' medications for appropriateness, as well as any potential side effects of their prescriptions.

Delmarva's collaboration was unique across the nation in that it involved local schools of pharmacy and targeted actions of community-based pharmacists.

"This initiative is win-win for providers, Medi-CareFirst, pharmacists and especially patients. Medicare beneficiaries have been able to take advantage of the knowledge and expertise of community pharmacists to help them understand their medications and to take more control of managing their own health," said Carmen Tyler Winston, Vice President, Delmarva Foundation. "In addition to providing increased access to prescription drug coverage, this program helps create a higher quality of care for Medicare beneficiaries in Maryland and the District of Columbia who are taking prescription medications."

State by state details of how other QIOs are working in partnership with Medicare Part D prescription drug plans (PDPs) and Medicare Advantage plans (MA-PDs) to improve the quality of prescription drug therapy for Medicare beneficiaries are reported in a Supplement to the July/August Journal of Managed Care Pharmacy. http://amcp.org/data/jmcp/July%20B%20Supplement.pdf

Delmarva Foundation is a national, not-for-profit organization dedicated to improving healthcare quality in over 30 states. Since 1973, Delmarva has assisted in enhancing care in hospitals, nursing homes, home health agencies, medical practices and health plans. Delmarva conducts work that includes quality improvement, quality assurance, utilization review and external quality review. The company's corporate headquarters are located in Easton, Maryland with other offices in Baltimore, Maryland; Washington, DC; Columbia, South Carolina; and Tampa and Tallahassee, Florida. For more information, please visit Delmarva Foundation on the web at http://www.delmarvafoundation.org.

8SOW-MD/DC-HOSP-091307-0043

This material was prepared by Delmarva Foundation, the Medicare Quality Improvement Organization for Maryland and the District of Columbia, under contract with the Centers for Medicare & Medicaid Services, an agency of the U.S. Department of Health and Human Services.


'/>"/>
SOURCE Delmarva Foundation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Woodruff Foundation Grant To Support Doctorate Of Nursing Practice Program
2. Kalam To Lay Foundation Of Vellore Research Center
3. Nippon Foundation To Help Leprosy Patients
4. Parents Launch SV40 Cancer Foundation In Memory of Son
5. Cancer Aid And Research Foundation: Offering Endless Hope To Cancer Patients
6. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
7. PM Launches Healthcare Foundation For India
8. Prime Minister Manmohan Singh, Flags Off Public Health Foundation of India
9. Gates Foundation to donate USD 104 million to TB Alliance
10. MoU for HIV/AIDS Signed by Nigeria and Clinton Foundation
11. Gates Foundation Adopts Fight against Encephalitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, ... M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... the most handsome men, look naturally attractive. Plastic surgery should be invisible.” He ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... Any dentist who has made an implant supported ... Many of them do not even offer this as a ... laboratory costs involved. And those who ARE able to offer ... high cost that the majority of today,s patients would not ... Zadeh , founder of Dental Evolutions Inc. and inventor of ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: